Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
12 hedge funds and large institutions have $15.8M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.14% less ownership
Funds ownership: 3.79% → 0.64% (-3.1%)
45% less capital invested
Capital invested by funds: $28.7M → $15.8M (-$12.8M)
Holders
12
Holding in Top 10
–
Calls
$25.9M
Puts
$7.53M
Top Buyers
| 1 | +$1.38M | |
| 2 | +$1.38M | |
| 3 | +$926K | |
| 4 |
Jane Street
New York
|
+$551K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$415K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$356K | |
| 3 | -$279K | |
| 4 |
Citigroup
New York
|
-$248K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$160K |